NFA
CPXX

Nationwide Fund Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Nationwide Fund Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,417
Closed -$646K – 3305
2016
Q2 		$646K Buy
+21,417
New +$435K ﹤0.01% 2004

Nationwide Fund Advisors's CPXX Position: Q3 2016 in Review

Nationwide Fund Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 21,417 shares — an estimated $646K sold.

Nationwide Fund Advisors first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $646K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Nationwide Fund Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 21,417 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $646K.
  • Nationwide Fund Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Nationwide Fund Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $646K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Nationwide Fund Advisors's 13F filing for Q3 2016, filed 20 Oct 2016.